Fundraising FoxExostemtech Venture Capital
Ansan, KR · 2 known investors
Find your way into Exostemtech Venture Capital
Sign up to see every warm intro you have to Exostemtech Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exostemtech Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
Investors · 2
Frequently asked questions
- What does Exostemtech Venture Capital do?
- Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
- Who are Exostemtech Venture Capital's investors?
- Exostemtech Venture Capital's investors include IMM Investment Japan, We Ventures.
- Where is Exostemtech Venture Capital headquartered?
- Exostemtech Venture Capital is headquartered in Ansan, KR.